Documenti analoghi

• The clinical features, risk factors and outcomes of polyomavirus encephalitis after allogeneic haematological stem cell transplantation
  di: Xu‐Ying Pei, et al.
  Pubblicazione: (2025)
• Outcomes and risk factors of second allogeneic haematopoietic stem cell transplantation in patients with relapsed haematological malignancy after first transplantation
  di: Xiaolu Zhu, et al.
  Pubblicazione: (2025)
• Monitoring the KMT2A gene post‐chemotherapy independently predicts the relapse and survival risk after allogeneic haematopoietic stem cell transplantation
  di: Jing Liu, et al.
  Pubblicazione: (2025)
• Mega‐dose decitabine conditioning and prophylactic donor lymphocyte infusion for patients with relapsed/refractory AML with active disease at the time of allogeneic haematopoietic cell transplantation: A multicenter prospective phase II study
  di: Meng Lv, et al.
  Pubblicazione: (2024)
• Clinical and genetic profiles and outcomes of allogeneic haematopoietic stem cell transplantation in secondary myelodysplastic syndrome following aplastic anaemia
  di: Jia Li, et al.
  Pubblicazione: (2024)